NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that total fourth quarter 2014 revenues increased 32 percent year over year.

The San Diego-based company said that for the last three months of 2014, it took in $512.4 million in total revenues, up from $387.3 in the year ago quarter. Product revenues climbed 34 percent in the quarter to $450.3 million from $336.4 million in Q4 2013, while service revenue grew 22 percent to $62.1 million from $50.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.